The study of pro-inflammatory and anti-inflammatory cytokines in patients with diabetic chronic kidney disease
Abstract
Chronic renal failure in diabetes mellitus remains one of the most urgent promotions of medicine due to severe clinical complications, loss of ability to work, and high mortality rates. About 80% of Type II diabetes mellitus suffers from renal failure. Gradual destruction of nephrons in diabetes and sclerosis and fibrosis of kidney parenchyma leads to irreversible chronic renal failure. In addition to non-immune processes, immune disorders also play an important role in the complication of chronic renal failure. In recent years, cytokines have been found to be of particular importance in immune changes. The purpose of our research is to provide a comparative analysis of inflammatory and inflammatory cytokines in the blood serum of patients with chronic diabetes-related chronic renal failure.
References
Atkins R. C., Zimmet P. Diabetic kidney disease: act now or pay later. Kidney International. 2010;77(5):375–377.
Cooper M. E. Diabetes: treating diabetic nephropathy-still an unresolved issue. Nature Reviews Endocrinology. 2012;8(9):515–516.
Ritz E., Rychlik I., Locatelli F., Halimi S. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. American Journal of Kidney Diseases. 1999;34(5):795–808.
Atkins R. C. The epidemiology of chronic kidney disease. Kidney International, Supplement. 2005;67(94):S14–S18.
Wolf G. New insights into the pathophysiology of diabetic nephrophathy: from haemodynamics to molecular pathology. European Journal of Clinical Investigation. 2004;34(12):785–796.
Martini S., Eichinger F., Nair V., Kretzler M. Defining human diabetic nephropathy on the molecular level: integration of transcriptomic profiles with biological knowledge. Reviews in Endocrine and Metabolic Disorders. 2008;9(4):267–274.
Wada J., Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clinical Science. 2013;124(3):139–152.
Pickup J. C., Mattock M. B., Chusney G. D., Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 1997;40(11):1286–1292.
Keywords
chronic renal failure
hemodialysis treatment Сахарный диабет
хроническая почечная недостаточность
лечение гемодиализом Şəkərli diabet
xroniki böyrək çatışmazlığı
hemodializ müalicəsi